Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
The omega-3 fatty acids are extracted from New Zealand green lipped mussels and developed into oils for use in anti-inflammatory compounds by our UK based clients. More
The first topical protease inhibitor with antibacterial properties discovered and patented by Vitro-Bio. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2007 - 126 pages - $2,495
Feb 2012 - 68 pages - $1,085
Dec 2009 - 84 pages - $7,600
May 2011 - 15 pages - $250
Feb 2012 - 70 pages - $1,085
Mar 2011 - 22 pages - $125
May 2008 - 85 pages - $1,995
Feb 2012 - 58 pages - $1,085
Mar 2011 - 35 pages - $125
Jan 2011 - 15 pages - $99
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Aphthous ulcers
- Dental disorder (other)
- Gingivitis
- Gum disease
- Herpes simplex virus type 1 (oral)
- Mouth disorder (other)
- Mucositis oral
- Mucositis, Radiation-induced
- Periodontal disease
- Tooth decay
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us